1 Many types of culture media contain a pH-sensitive dye. One commonly occurring dye, Phenol red sodium (Na þ ) salt, was tested for blocking activity at rat P2X 1À4 receptors (P2X 1À4 Rs) expressed in Xenopus oocytes. 2 Phenol red Na þ -salt antagonised adenosine 5 0 -triphosphate (ATP) responses at P2X 1 R (IC 50 , 3 mM) and, at higher concentrations, also blocked P2X 2 R and P2X 3 R. Phenol red Na þ -salt, purified of lipophilic contaminants, blocked P2X 1 R and P2X 3 R by acting as an insurmountable antagonist. 3 Two lipophilic extracts of Phenol red antagonised ATP responses at P2XRs. Extract A was a potent antagonist at P2X 1 R (IC 50 , 1.4 mM), whereas extract B was a potent antagonist at P2X 3 R (IC 50 , 4.1 mM). A bisphenolic compound (RS151030) found in these extracts was a potent antagonist at P2X 1 R (IC 50 , 0.3 mM) and at P2X 3 R (IC 50 , 2.4 mM). 4 Phenolphthalein base was a potent irreversible antagonist at P2X 1 R (IC 50 , 1mM), whereas Phenolphthalein K þ -salt was 25-fold less potent here. 5 Phenolphthalein base was a reversible antagonist of ATP responses at rat P2X 4 R (IC 50 , 26 mM), whereas Phenolphthalein K þ -salt was inactive. 6 Dimethyl sulphoxide (DMSO), used to dissolve lipophilic extracts, showed pharmacological activity by itself at rat P2X 1 R and P2X 4 R. 7 Thus, Phenol red and related compounds are antagonists at rat P2X 1 R, but are also active at other rat P2XRs. Phenolphthalein base is a newly identified, low potency antagonist of ATP responses at P2X 4 R. Culture media containing these red dyes should be used cautiously in future pharmacological studies of P2XRs. Also, wherever possible, the solvent DMSO should be used with caution.
Introduction
P2X receptors (P2XRs) are ligand-gated ion-channels (LGICs) that are widely distributed among various tissue types, including neurons, retinal cells, glia, cardiac and smooth muscles, secretory epithelia, haemopoietic cells and blood platelets (Khakh et al., 2001; North, 2002) . P2XRs are activated by extracellular adenosine 5 0 -triphosphate (ATP) and, when activated, affect their host cell in three well-defined ways: (i) influx of extracellular sodium ions to cause depolarisation; (ii) influx of extracellular calcium ions to activate intracellular mechanisms; (iii) for the P2X 7 R subtype in particular, channelto-pore conversion with the loss of size-and charge-selectivity for channel permeants (Khakh et al., 2001; North, 2002) .
Seven subunits are involved in the construction of mammalian P2XRs -the P2X 1 to P2X 7 proteins. Each subunit is capable of forming functional homomeric assemblies, which comprise three identical externally glycosylated proteins (Nicke et al., 1998; Rettinger et al., 2000; Khakh et al., 2001; North, 2002; Jiang et al., 2003; Aschrafi et al., 2004) . The number of functional homomeric P2XRs in a cell appears to depend on the trafficking efficiency of P2X subunits from the endoplasmic reticulum to the membrane North, 2002; Aschrafi et al., 2004) although, for P2X 6 R, it also depends on the efficiency of subunit glycosylation (Jones et al., 2004) . Thus, studies of homomeric P2X 1À4 R subtypes are relatively straightforward because these four subtypes are expressed well in all heterologous systems (Khakh et al., 2001; North, 2002) . On the other hand, homomeric P2X 5 R and P2X 6 R subtypes are difficult to study because the number of functional receptors on the cell surface is exceedingly low in all expression systems tested King et al., 2000; North, 2002; Wildman et al., 2002; Aschrafi et al., 2004; Jones et al., 2004) . The P2X 7 R subtype is expressed well in the oocyte expression system, but this receptor is difficult to control pharmacologically once the channel-to-pore transition has been initiated (Nuttle & Dubyak, 1994) .
It is now a feature of modern pharmacological investigations to study P2XRs either in primary cultures of acutely dissociated cells (e.g. DRG, neuronal, platelet, retinal and smooth muscle cells), or in secondary cultures of immortalised cells (e.g. MDCK and J774 cells), or as recombinant protein assemblies expressed in mammalian cell types (e.g. CHO-K1, HEK 293 and 1321-N1 astrocytoma cells)). In many cases, cells are bathed in culture media containing the pH indicator dye, Phenol red sodium (Na þ ) salt. The concentration of this agent varies from 3 to 50 mM in culture media (based on the dye content of commercially available media), such as Ham (F10 or F12) solution (3 mM); Roswell Park Memorial Institute (RPMI) medium (12 mM); basal medium Eagle (BME, 25 mM); minimum essential medium (MEM; 25 mM); Hank's balanced salt solution (30 mM); Dulbecco's modified Eagle medium (DMEM, 35 mM) and medium 199 (50 mM); Connaught Medical Research Lab (CMRL) medium (50 mM).
The notion that Phenol red Na þ -salt might exert pharmacological actions at ligand-gated membrane receptors such as the P2XR family has not been explored until now, although this pH indicator dye does not noticeably affect voltage-gated Na þ -, K þ -and Ca 2 þ -selective ion-channels in squid axon (Mullins et al., 1983) . However, lipophilic impurities of Phenol red are known to affect cation transporters in some cell types (Hopp & Bunker, 1993; Kym et al., 1996) and to antagonise thromboxane-A 2 receptors in human platelets and canine arteries (Greenberg et al., 1994) . Additionally, lipophilic impurities in Phenol red have either cytotoxic or oestrogenic/ proliferative actions at a number of primary and secondary cell cultures (Berthois et al., 1986; Bindal et al., 1988; Ernst et al., 1989; Grady et al., 1991; Raam, 1992) . Here, we report the blocking actions of commercially available Phenol red Na þ -salt -and several related compounds -on recombinant isoforms of rat P2X 1À4 R subtypes at drug concentrations relevant to cell culture conditions. Part of this study has appeared in Abstract form (King et al., 2003) .
Methods

Oocyte preparation
Xenopus laevis frogs were anaesthetised in Tricaine (0.4% w v À1 ), killed by decapitation and the ovarian lobes removed surgically. Isolated oocytes (stages V and VI) were treated with collagenase (Type IA, 2 mg ml À1 in a Ca 2 þ -free Ringer's solution, for 2 h) to break down the follicle cell layer that envelops each oocyte. Thereafter, oocytes were shrunk using a double-strength, hyperosmotic Ca 2 þ -free Ringer's solution and the loosely adherent follicle cell layer was removed using fine forceps. Freshly prepared defolliculated oocytes were stored in Barth's solution (pH 7.50) containing NaCl, 110 mM; KCl, 1 mM; Tris-HCl, 7.5 mM; Ca(NO 3 ) 2 , 0.33 mM; CaCl 2 , 0.41 mM; MgSO 4 , 0.82 mM; NaHCO 3 , 2.4 mM; gentamycin sulphate, 50 mg l
À1
. Defolliculated oocytes do not possess functional adenosine and ATP receptors (King et al., 1996a, b) . Also, these large single cells are deficient in cellsurface ATPases (Ziganshin et al., 1995) that are often inhibited by P2 receptor antagonists (Ziganshin et al., 1996) .
Electrophysiological recordings
cRNA (40 nl, 1 mg ml
À1
) for either rat P2X 1 R, P2X 2 R, P2X 3 R or P2X 4 R was injected into the cytosol of defolliculated oocytes. Injected oocytes were left for 48 h at 181C in Barth's solution and, thereafter, kept for up to 7 days at 41C in Barth's solution until used in electrophysiological experiments. ATPactivated membrane currents (I ATP ) were recorded from cRNA-injected oocytes using twin microelectrode, voltageclamp techniques (Axoclamp 2A & 2B amplifiers; Axon Instruments, Union City, CA, U.S.A.). The voltage-and current-recording microelectrodes (0.5-2.0 MO) were filled with a filtered 3 M KCl solution. Oocytes were placed in a recording chamber (0.5 ml capacity) and superfused (5 ml min
) with a Ringer's solution (181C; adjusted to pH 7.50 with either NaOH or HCl) containing NaCl, 110 mM; KCl, 2.5 mM; HEPES, 5 mM and BaCl 2 , 1.8 mM. Recordings were stored on magnetic tapes using a DAT recorder (Sony 1000ES) and displayed on a WindoGraf 900 thermal array recorder (Gould Nicolet Technologies, Ilford, Essex, U.K.).
Drug actions
In oocyte experiments, recombinant P2XRs were activated by extracellular ATP, which was applied for 60 s or until evoked currents reached their peak amplitude. ATP was reapplied after a period of 20 min washout, an interapplication interval that provided agonist responses of identical amplitude (Wildman et al., 1999) and twice as long as the time needed for internalised P2X subunit proteins to return to the cell surface (Ennion & Evans, 2001) . Agonist concentration/response curves were constructed by using increasing concentrations of ATP and normalising evoked responses to the maximum current elicited by ATP. EC 50 values for ATP were determined from Hill plots of the transform (I/I max ÀI), where I is the peak current evoked by each ATP concentration. Values of the Hill coefficient (n H ) were also taken from these transforms. Graphs were drawn using Prism v2.0 (GraphPad Software, San Diego, CA, U.S.A.), and significant statistical differences between data points were determined by Student's t-test (using Instat v2.05A, GraphPad).
Antagonists were applied for 20 min prior to, and during, the application of the agonist ATP. Here, ATP was used at the approximate EC 75 concentration: P2X 1 R, 3 mM; P2X 2 R, 30 mM; P2X 3 R, 3 mM; P2X 4 R, 10 mM. Increasing concentrations of antagonists were applied and the degree of inhibition of ATP responses determined by normalising data to the mean current of three control applications of ATP (at the EC 75 concentration) in the absence of the antagonist. Inhibition curves were ). Fluorescence was measured every 1 s for 120 s after agonist addition. Peak fluorescence in response to the addition of a,bmeATP was measured in both the absence and presence of antagonists.
Whole-cell recordings from CHO-rP2X 3 cells
Whole-cell recordings were made under voltage-clamp conditions from CHO-K1 cells stably expressing rat P2X 3 subunits. Cells were plated onto poly-D-Lysine coated coverslips and incubated in a growth medium (L-15) for 1-4 days at 371C. Recordings were made using an Axopatch-IC amplifier (Axon Instruments, Foster City CA, U.S.A.), with cells held at À60 mV. Recording electrodes (resistance 1-4 MO) were filled with an intracellular solution containing KCl, 120 mM; HEPES, 10 mM; potassium citrate, 10 mM; pH 7.2. CHOrP2X 3 cells were superfused with Dulbecco's phosphatebuffered saline (supplemented with CaCl 2 , 1mM; MgCl 2 , 0.5 mM). Data were acquired using pCLAMP 9 software (Axon Instruments) and signals were filtered at 2 kHz (À3 dB frequency, Bessel filter, 80 dB decade À1 ). Drugs (5 mM stock solution diluted in extracellular buffer) were delivered by gravity flow and regulated by a Valvebank II system (Automate Scientific, San Francisco CA, U.S.A.). CHOrP2X 3 R cells were activated with abmeATP (10 mM, 3 s every 4 min) until reproducible inward currents were obtained. Thereafter, CHO-rP2X 3 cells were superfused with Phenol red Na þ -salt (in extracellular buffer) for 4 min followed by abmeATP (10 mM, 3 s). After washout (4 min), cells were challenged again with abmeATP (10 mM, 3 s).
Whole-cell recordings from HEK 293 cells
HEK 293 cells were maintained in Phenol red-free DMEM (Sigma-Aldrich Chemical Co., Poole, Dorset, U.K.) and transiently transfected, as described in Schorge & Colquhoun (2003) , with the rat P2X 1 receptor cDNA. A reporter gene, green fluorescent protein (GFP), was also included in transfections to identify cells for whole-cell voltage-clamp experiments. At 3 days post-transfection, abmeATP (1 mM) evoked inward currents were recorded from HEK 293 cells using the whole-cell recording conditions described in Valera et al. (1994) . The agonist was applied via a Y-tube positioned close to GFP-labelled cells (o100 mm). When used, Phenol red Na þ -salt was applied for at least 30 min prior to recording at a concentration of 100 mM.
Drug purification and solutions
Phenol red (phenolsulphonephthalein sodium (Na þ ) salt), Phenolphthalein base (3,3-bis[4-hydroxyphenol]-1(3H)-isobenzofuranone) and Phenolphthalein disulphate potassium salt ( Figure 1 ) were obtained from Sigma-Aldrich Chemical Co. (Poole, Dorset U.K.). Phenol Red (listed as 90% pure) was cleared of lipophilic impurities by an earlier, established method (Bindal et al., 1988; Grady et al., 1991) . Briefly, commercially available Phenol red was partitioned between water and diethyl-ether and the two phases separated. Excess ether was removed from the aqueous phase under vacuum. The nonaqueous phase was concentrated, dried and the residue redissolved in ethanol. Separation by reverse-phase HPLC yielded two major lipophilic extracts (A and B) (Grady et al., 1991; Kym et al., 1996) . One compound known to be present Figure 1 Chemical formula, molecular weight and structure of the pH-sensitive dyes, Phenol red sodium salt, Phenolphthalein base and Phenolphthalein disulphate potassium salt.
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Phenol red blockade of rat P2XRs in these lipophilic extracts -Compound 5 (9,9-bis[4-hydroxyphenol]-3-hydroxyfluorene) and, here, renamed RS151030 -was synthesised de novo according to an earlier specified protocol (Kym et al., 1996) . ATP (adenosine 5 0 -triphosphate disodium salt) was obtained from Sigma-Aldrich Chemical Co. (Poole, Dorset). Other chemicals were Analar grade from Sigma-Aldrich. ATP and Phenol red sodium salt were dissolved in a Ca 2 þ -free Ringer's solution (pH 7.50). Phenolphthalein base and lipophilic extracts of Phenol red were dissolved in dimethyl sulphoxide (DMSO) to give stock solutions of 10 mM and, thereafter, diluted with Ringer's solution to give a range of drug concentrations (0.1-100 mM), which also contained a smallyet pharmacologically active -amount of DMSO (0.001-1% v v À1 ) (see below).
Results
Blockade by phenol red
Unless stated otherwise, ATP was used in all experiments at the approximate EC 75 concentration: P2X 1 R, 3 mM; P2X 2 R, 30 mM; P2X 3 R, 3 mM; P2X 4 R, 10 mM. Commercially available Phenol red Na þ -salt (100 mM) blocked ATP responses at the rat isoform of homomeric P2X 1 R, P2X 2 R and P2X 3 R, but was not active at P2X 4 R (Figure 2a ). Phenol red antagonism at these three P2XR subtypes was concentration-dependent ( Figure 2b ). At P2X 1 R, the threshold concentration for receptor blockade by Phenol red was 0.3 mM, with full blockade at 100 mM. At P2X 3 R, the antagonist was approximately 10-fold less potent; the threshold concentration for blockade was 3 mM and full blockade occurred at 1 mM. At P2X 2 R, the inhibition curve was steep with the threshold concentration for blockade at 30 mM and full blockade at 300 mM. The IC 50 values (mean7s.e.m., n ¼ 4), and n H values, for inhibition curves were: P2X 1 R, 3.070.6 mM (n H ¼ À1.070.2); P2X 2 R, 51.977.8 mM (n H ¼ À1.670.2); P2X 3 R, 24.374.4 mM (n H ¼ À0.970.2). At P2X 4 R, Phenol red was inactive at concentrations up to 100 mM. Phenol red was not tested at P2X 5 , P2X 6 or P2X 7 receptors.
After removing lipophilic constituents with diethyl-ether, purified Phenol red Na þ -salt still blocked ATP responses at P2X 1 and P2X 3 receptors (Figure 3a, b) . There was no significant difference between the blocking activities of either purified or commercial Phenol red. IC 50 (and n H ) values for the purified salt were P2X 1 R, 2.970.5 mM (n H ¼ À1.070.2); P2X 3 R, 27.676.8 mM (n H ¼ À0.870.2). The purified salt was also tested against the ATP concentration-response relationship for P2X 1 and P2X 3 receptors to determine the nature of receptor blockade (Figure 3c, d) . At P2X 1 R, Phenol red (PR: 0, 1, 3 and 10 mM) suppressed the maximum ATP activity without significantly altering the EC 50 value for ATP (mean7s.e.m., n ¼ 4): control, 1.070.1 mM; PR 1 mM, 0.770.1 mM; PR 3 mM, 0.470.1 mM; PR 10 mM, 0.470.1 mM. At P2X 3 R, Phenol red (PR: 0, 10, 30 and 100 mM) suppressed the maximum ATP activity without significantly altering ATP potency (mean7 s.e.m., n ¼ 4): control, 0.870.2 mM; PR 10 mM, 1.170.4 mM; PR 30 mM, 0.470.1 mM; PR 100 mM, 0.570.1 mM. Thus, Phenol red acted as a noncompetitive antagonist at these two P2XR subtypes. P2X 1 and P2X 3 receptors were in contact with purified Phenol red Na þ -salt for several hours while constructing concentration-response curves for ATP. Thus, antagonist data were analysed further to reassess the degree of blockade of ATP at the EC 75 value (3 mM) and to see if there was a usedependency for the antagonist (Figure 3e , f). For these inhibition curves, antagonism maxima and minima were estimated from earlier inhibition curves. The resultant IC 50 (and n H ) values were (mean7s.e.m., n ¼ 4): P2X 1 R, 1.070.1 mM (n H ¼ À0.870.1); P2X 3 R, 17.372.2 mM (n H ¼ À1.370.2). Here, the IC 50 value for Phenol red at P2X 1 R was significantly lower (Po0.05), and this increased potency supports the likelihood of use-and time-dependent block with this drug.
Blockade by Phenolphthalein base
Commercially available Phenolphthalein base blocked ATP responses at the rat P2X 1 R, P2X 3 R and P2X 4 R, but was much less effective at blocking P2X 2 R (Figure 4a, c) . Antagonism at these P2XR subtypes was concentration-dependent. At P2X 1 R, the threshold concentration for receptor blockade was 0.1 mM, with full blockade at 100-300 mM. At P2X 3 R, the antagonist was approximately 10-fold less potent; the Figure 2 Whole-cell inward currents (in a) evoked by ATP (given at the EC 75 , in mM) at rat isoforms of P2XR subtypes were antagonised by Phenol red Na þ -salt (PR, 100 mM) at P2X 1 R, P2X 2 R and P2X 3 R but not P2X 4 R. P2XRs were expressed in Xenopus oocytes, which were held under voltage-clamp conditions (V h ¼ À60 mV; each pair of records from the same cell). Inhibition curves (in b) for Phenol red Na þ -salt antagonism of ATP responses at four P2XRs, with ATP used at the EC 75 concentration (P2X 1 R, 3; P2X 2 R, 30; P2X 3 R, 3; P2X 4 R, 10 mM). Data points are given as mean7s.e.m. (n ¼ 4).
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Phenol red blockade of rat P2XRs threshold concentration for blockade was 1 mM and full blockade occurred at 300 mM. At P2X 4 R, the inhibition curve was steep -with the threshold concentration for blockade at 2 mM and full blockade at 300 mM. In contrast to Phenol red Na þ -salt experiments, Phenolphthalein base was a very weak antagonist at the P2X 2 receptor. The IC 50 (and n H ) values for inhibition curves were (mean7s.e.m., n ¼ 4): P2X 1 R, 1.770.3 mM (n H ¼ À0.770.2); P2X 3 R, 17.975.2 mM (n H ¼ À0.870.2); P2X 4 R, 25.974.7 mM (n H ¼ À1.770.5). At P2X 2 R, the IC 50 value for Phenolphthalein base was estimated as greater than 200 mM.
Phenolphthalein base is water insoluble and, therefore, it was necessary to use the nonaqueous DMSO as a solvent. Control experiments with this vehicle showed that P2XRs were, to varying degrees, sensitive to DMSO (Figure 4b ). P2X 1 R was most sensitive showing up to 25% reduction of the amplitude of ATP responses with dilutions of 0.01-1.0% (v v À1 ) of DMSO in Ringer's solution. P2X 2 R and P2X 3 R were less sensitive and showed less than 10% reduction of ATP responses over the same range of dilutions. P2X 4 Rs showed a modest potentiation of ATP responses -by about 15% -using high dilutions (0.001-0.01%) of DMSO, and this effect declined as lesser dilutions were tested. Since Phenolphthalein base was made up as stock solutions of 10 mM, the subsequent reduction of antagonist stocks to a concentration of 100 mM meant that these solutions contained 1% DMSO, whereas an antagonist concentration of 0.1 mM contained 0.001% DMSO.
The inhibition curves for Phenolphthalein base at P2X 1À4 Rs were reanalysed and redrawn, using a subtractive process to take into account the effect of DMSO at each dilution factor (Figure 4c ). Here, this process involved subtracting the mean amplitude of the potentiating or inhibitory effects of DMSO (as a percentage of control response) from the data for Phenolphthalein base. Under these circumstances, IC 50 values were (mean7s.e.m., n ¼ 4): P2X 1 R, 1.070.2 mM; P2X 3 R, 17.975.2 mM; P2X 4 R, 25.875.4 mM; P2X 2 R, 4200 mM. None of these IC 50 values were significantly different from the original determinations.
P2XRs were tested for the recovery of agonist activity from Phenolphthalein base antagonism after a 40-min period of drug washout ( Figure 5 ). For P2X 1 R, Phenolphthalein (100 mM) blockade was irreversible with only a 5.971.1% Figure 3 Inhibition curves for commercially available and purified Phenol red Na þ -salt (PR) at the rat isoform of P2X 1 R (in a) and P2X 3 R (in b). Purified PR was tested for noncompetitive antagonism of responses to extracellular ATP (3 mM, the EC 75 ) at P2X 1 R (in c) and P2X 3 R (in d). In (c) and (d), data in parentheses give the mean EC 50 values for ATP with the stated concentrations of purified PR present. Inhibition curves for purified PR at P2X 1 R (in e) and P2X 3 R (in f) were redrawn from data in (c) and (d) using the data for 3 mM ATP (EC 75 value). Additionally, maxima and minima (filled symbols) for the inhibition curves in (e) and (f) were taken from earlier data in (a) and (b). All data points are expressed as mean7s.e.m. (n ¼ 4).
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Blockade by Phenolphthalein salt
Phenolphthalein disulphate potassium (K þ ) salt (Figure 1c ) was tested at P2X 1À4 Rs for blocking activity (Figure 6 ). At the P2X 1 R, ATP responses were blocked by this compound with an IC 50 value of 26.173.2 mM (n H ¼ À0.670.3) (mean7s.e.m., n ¼ 4). The IC 50 values for P2X 2 R and P2X 3 R were estimated as in excess of 200 mM, whereas the compound was not active at P2X 4 R.
Blockade by lipophilic extracts of Phenol red
HPLC analysis of lipophilic extracts of Phenol red has revealed two major peaks (Grady et al., 1991; Kym et al., 1996) and chromatographic separation yielded extracts A and B, which were tested against ATP responses at P2X 1 R and P2X 3 R. At P2X 1 R, extract A was more potent than extract B as an inhibitor of ATP responses (Figure 7a ). For extract A, the threshold concentration for blocking activity was 0.1 mM and maximal inhibition occurred at 100 mM. For extract B, the threshold was 3 mM and maximal at 300 mM. IC 50 (and n H ) values were (mean7s.e.m., n ¼ 4): extract A, 1.470.4 mM; extract B, 39.275.4 mM (after adjusting for the DMSO effect). These IC 50 values were significantly different (Po0.01). At P2X 3 R, both extracts were equipotent as antagonists of ATP responses (Figure 7b ). The threshold for blockade was 0.3 mM and maximal inhibition occurred at 100 mM. The IC 50 (and n H ) values were (mean7s.e.m., n ¼ 4): extract A, 5.071.7 mM (n H ¼ À0.870.2); extract B, 4.170.8 mM (n H ¼ À0.870.2). Comparing IC 50 values, both extracts were more potent than Phenol red Na þ -salt (Po0.01). ) on ATP responses at four P2XRs. In (c), inhibition curves for Phenolphthalein base were reanalysed and redrawn using a subtractive process to take into account the effects of DMSO. All data points are expressed as mean7s.e.m. (n ¼ 4); *Po0.05. Figure 5 Whole-cell currents inward currents evoked by ATP (given at the EC 75 , in mM; P2X 1 R, 3; P2X 4 R, 10) at the rat isoform of P2X 1 R (upper records) and P2X 4 R (lower records). At P2X 1 R, ATP responses were antagonised in an irreversible manner by Phenolphthalein base (PTB, 0-100 mM). At P2X 4 R, ATP responses were antagonised in a reversible manner by PTB (2-200 mM). Recovery from PTB antagonism was tested after a 40-min period of drug washout (W). Each set of records is from separate cells, held under voltage-clamp (V h ¼ À60 mV). Blockade by the lipophilic compound RS151030
One compound identified in lipophilic extracts of Phenol red was Compound 5 (9,9-bis[4-hydroxyphenol]-3-hydroxyfluorene) (Figure 8a ) (Kym et al., 1996) . This compound was resynthesised, renamed RS151030 and tested against ATP responses at P2XRs. At the P2X 1 R, the threshold concentration for receptor blockade was 0.03 mM, with full blockade at 10 mM (Figure 8b ). At the P2X 3 R, RS151030 was about 10-fold less potent with a threshold of 0.3 mM and full blockade in excess of 10 mM (Figure 8b 
Antagonism of P2XRs in mammalian cells
The antagonist activity of Phenol red Na þ -salt was retested at P2XRs expressed in mammalian cell systems (human P2X 1 R, in CHO-KI cells; rat P2X 1 R, in HEK 293 cells; human P2X 3 R, in 1321-N1cells; rat P2X 3 R, in CHO-K1). Then, the results from either fluorimetric (FLIPR) or whole-cell current measurements of P2X activation in these expression systems were compared against data from experiments carried out in Xenopus oocytes expressing rat orthologues of these P2XRs.
Fluo-3 fluorescence signals, in response to Ca 2 þ -influx caused by a,bmeATP activation of human P2X 1 R expressed in CHO-K1 cells, were inhibited by 5573% (mean7s.e.m.; n ¼ 9) by Phenol red Na þ -salt (100 mM) (Figure 9 ). This inhibitory activity was significantly less than the inhibition (9473%, n ¼ 4) caused by Phenol red Na þ -salt (100 mM) blockade of inward currents evoked by a,bmeATP activation of rat P2X 1 Rs expressed in oocytes. With human P2X 3 R in 1321-N1 cells or rat P2X 3 R expressed in CHO-K1, Phenol red Na þ -salt (100 mM) inhibited in equal measure the Ca 2 þ -stimulated Fluo-3 fluorescence in response to a,bmeATP activation of these P2X 3 R subtypes (Figure 9 ). Here, Fluo-3 signals were inhibited by 4572% (human P2X 3 R in 1321-N1; n ¼ 6) and 4472% (rat P2X 3 R in CHO-K1; n ¼ 6) by Phenol Red Na þ -salt. Yet again, the degree of inhibition was significantly less than the inhibition (8175%, n ¼ 4) caused by Phenol red Na þ -salt (100 mM) blockade of inward currents evoked by a,bmeATP-activation of rat P2X 3 Rs expressed in oocytes.
In a second set of comparative experiments, inward wholecell currents in response to a,bmeATP activation of GFPtagged rat P2X 1 R expressed in HEK293 cells were completely inhibited by Phenol red Na þ -salt (Figure 9 ), whereas responses to a,bmeATP activation of rat P2X 1 R expressed in oocytes was inhibited almost by the same extent (9473%, n ¼ 4) by this antagonist. For rP2X 3 Rs stably expressed CHO-K1 cells, Phenol red Na þ -salt (100 mM) inhibited a,bmeATP responses by 9371% (n ¼ 3) (Figure 9 ), whereas responses to 2 þ -imaging experiments. a,bmeATP (in mM) was applied at the EC 75 concentration for each P2XR isoform in the following expression systems: (CHO-K1/hP2X 1 R, 0.1; oocyte/rP2X 1 R, 3.0; HEK293/rP2X 1 R, 1.0; 1231-N1/hP2X 3 R, 0.3; CHO-K1/rP2X 3 R, 0.3; oocyte/rP2X 3 R, 3.0; CHO-K1/rP2X 3 R, 10 mM).
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Phenol red blockade of rat P2XRs a,bmeATP activation of rat P2X 3 R expressed in oocytes were inhibited by a similar extent, 8175% (n ¼ 4), by this antagonist. Thus, in these comparative studies, Phenol red Na þ -salt was active at P2XRs tested in several mammalian expression systems and under all experimental conditions (fluorimetry and patch-clamp). However, when compared to oocyte data, the antagonist was less effective where Ca 2 þ -signals were measured, yet equally effective where inward currents were measured.
Discussion
This investigation revealed that a series of pH-sensitive dyesprincipally Phenol red Na þ -salt, but also two lipophilic extracts of Phenol red, the lipophilic compound RS151030, Phenolphthalein base and its K þ -salt -were antagonists of rat P2XRs expressed in oocytes. These compounds showed some selectivity towards the P2X 1 R subtype although, in near all cases, they also blocked the P2X 3 R subtype with a selectivity window for P2X 1 R over P2X 3 R of approximately 1 log 10 -unit of drug concentration. A summary of IC 50 values at rat P2X 1À4 Rs is given in Table 1 . Furthermore, this investigation demonstrated that the blocking activity of Phenol red Na þ -salt occurred at the concentrations found in culture media (3-50 mM; see Introduction) and that time-dependent blockade also occurred with prolonged exposure to this antagonist. Additionally, Phenol red Na þ -salt displayed antagonist activity at human P2X 1 R, rat P2X 1 R, human P2X 3 R and rat P2X 3 R expressed in mammalian cell lines (CHO-K1, 1321-N1 and HEK 293 cells). To this end, it is advised that future studies of recombinant P2XRs, in heterologous expression systems grown in culture, avoid the use of bathing solutions containing a pH-sensitive red dye -if this is at all possible.
Finally, the present investigation also revealed that the nonaqueous DMSO had an inhibitory action at P2X 1 R, and potentiating action at P2X 4 R. Thus, a measure of caution is also now required when using this solvent in drug studies of these P2XR subtypes.
Compared with other known P2X 1 R antagonists -for example, TNP-ATP (Virginio et al., 1998) , IP 5 I , PPNDS (Lambrecht et al., 2000) , MRS 2179 (Brown et al., 2000) , PPADS and its derivative MRS 2257 (Brown et al., 2001) , and NF449 (Braun et al., 2001 ) -the tested pHsensitive dyes were not remarkable in terms of their potency. Also, some of the better known P2X 1 R antagonists are competitive antagonists and their blocking actions are easily reversed -at least, when used in submicromolar concentrations -whereas purified Phenol red Na þ -salt was an insurmountable antagonist and its blocking actions were not rapidly reversed in vitro. The results of assays testing structurally related Phenolphthalein analogues -in either sulphonated or nonsulphonated forms -also failed to reveal a substantial improvement in antagonist potency at the P2X 1 R. Nonetheless, Phenol red Na þ -salt was found to be as effective as TNP-ATP as an in vivo antagonist of purinergic contractions mediated by P2X 1 -like receptors in the anaesthetised female rat urinary bladder , whereas P2X 1 R antagonists such as IP 5 I, PPADS, MRS 2179 and the novel P2X 1 R antagonist RO116-6446/008 were much less effective than Phenol red in this model . Also, it should be borne in mind that Phenol red and other pHsensitive dyes were antagonists at a number of other P2XR subtypes in addition to P2X 1 R and, to this extent, these compounds may still be useful in future experiments on these recombinant P2XR subtypes.
Of the dye compounds investigated, the single most remarkable finding was the blocking activity of Phenolphthalein base at the P2X 4 R. Since its isolation, the rat isoform of the P2X 4 R has been distinguished by its unique refractoriness to blockade by the better known P2 receptor antagonists (e.g. suramin, PPADS and Reactive blue-2; Buell et al., 1996) . However, the rat isoform can be blocked by TNP-ATP with a mean IC 50 value of 15 mM and blocked fully at 4100 mM (Virginio et al., 1998) . Phenolphthalein base gave a mean IC 50 value of 26 mM at rat P2X 4 R and showed full blockade at 200 mM. Therefore, in real terms, TNP-ATP and Phenolphthalein base could be considered equipotent -although TNP-ATP, as a nucleotide, is disadvantaged by being dephosphorylated and rendered less potent in vitro (Lewis et al., 1998) and in vivo (Honore et al., 2002) , whereas Phenolphthalein base is a stable compound and, furthermore, its blocking actions can be reversed with washout. It is hoped that Phenolphthalein base may prove promising as a reversible P2X 4 R antagonist in vivo. Furthermore, Phenolphthalein base was relatively inactive at P2X 2 R and, therefore, this compound could be used to distinguish the slowly desensitising P2X 4 R subtype from the P2X 2 R in vivo. It was also noted that blocking activity at the P2X 4 R was lost in the related Phenolphthalein K þ -salt and in Phenol red Na þ -salt which are both sulphonated. The absence of blocking activity by these sulphonated dyes may hold the key to explain the inactivity of many of the better known, yet sulphonated, P2 receptor antagonists at the rat P2X 4 R. Lastly, Phenolphthalein base has been much used as a stimulant laxative but, in this case, the base must be transformed into an alkaline salt by the intestine before it can act as an irritant to the colonic mucosa and a stimulant of peristalsis (Cass et al., 1965) . At either P2X 2 R or P2X 3 R, none of the tested compounds showed a higher potency than other known P2 receptor antagonists of these subtypes. Thus, Reactive blue-2 remains the most potent antagonist (mean IC 50 , 0.36 mM) at the rat P2X 2 R (King et al., 1997) and A317491 is one of the more potent (mean IC 50 , 0.1 mM) and highly selective antagonists at rat P2X 3 R (Jarvis et al., 2002) . None of the pH-sensitive dyes were tested at either rat P2X 5 R or rat P2X 6 R because they do not express well in oocytes Wildman et al., 2002) , nor were tested at rat P2X 7 R which is difficult to control and also behaves differently from human P2X 7 R, in terms of the reproducibility of agonist responses, when expressed in oocytes (Petrou et al., 1997; Klapperstu¨ck et al., 2001) . Regarding activity at P2YR subtypes, Phenol red Na þ -salt blocked the Xenopus p2y 8 R with an IC 50 value of 68711 mM (mean7s.e.m., n ¼ 4) (King & Liu, unpublished data) but did not block the human P2Y 11 R at a concentration up to 100 mM (King & Townsend-Nicholson, unpublished data) .
When tested against P2XRs, the lipophilic extracts of Phenol red and Phenolphthalein base required a nonaqueous solvent. DMSO was used but, by itself, showed blocking activity for ATP responses at P2X 1 R and a potentiating effect at P2X 4 R. This is not the first occasion that DMSO has been found to affect ion-channels. At 1% (v v À1 ), it selectively diminished acetylcholine responses at the nAChR receptor cloned from Torpedo electroplaque, although spared agonist responses at the murine nAChR receptor cloned from skeletal muscle (Eaton et al., 1997) . Other solvents -including ethanol and toluene at low dilutions (1% v v À1 and less) -also show either potentiating or inhibitory actions on ATP responses at P2X 2 R, P2X 3 R and P2X 4 R (Davies et al., 2002; Woodward et al., 2004) . Therefore, it was not possible to substitute either ethanol or toluene for DMSO as a solvent of lipophilic compounds in the present study.
DMSO was used to dissolve the two lipophilic extracts obtained from the commercially available Phenol red Na þ -salt. Although both lipophilic extracts showed blocking activity at P2X 1 R and P2X 3 R of similar potency to the salt itself, a sample of the purified and water-soluble Phenol red Na þ -salt was found to retain its blocking activity -without a reduction in potency -and, so, the salt must be considered as the principal pharmacological agent and not these extracts. The lipophilic extracts A and B represent a part of the stated 10% impurity of the commercially available Na þ -salt. It is likely that these extracts contain analogues of the Phenol red base which, except for a sulphone bridge, is similar in structure to Phenolphthalein base. However, the precise chemical nature of all the active compounds present in these two extracts was not elucidated. Nonetheless, one compound now known to be present is the bisphenolic molecule RS151030, which represents about 1% of the total dye content of commercially available Phenol red and about 10% of the lipophilic contamination (Kym et al., 1996) . This bisphenolic compound proved to be the most potent antagonist of all the dyes tested at P2X 1 R and P2X 3 R.
In summary, pH-sensitive dyes related in structure to Phenol red are antagonists primarily at the rat isoform P2X 1 R but are active to varying degrees at other rat and human P2XR subtypes. The base, Phenolphthalein, is additionally a reversible P2X 4 R antagonist and shows promise as a substance that might work in vivo. The presence of these dyes in culture media -especially for the more commonly used DMEM containing 35 mM Phenol red Na þ -salt -must surely complicate the study of native P2XRs in primary and secondary cultures, and of recombinant P2XRs in heterologous expression systems also bathed in culture media. Thus, it is recommended that culture media containing these red dyes should be avoided if possible in future studies of these LGICs -not only because of the already known oestrogen-like activity of these dyes but also for their ability to block P2XRs.
